MiR-25802: A Potential Target for Treating Alzheimer’s Disease
Author Information
Author(s): Zhao Kaiyue, Li Zixuan, Zeng Li, Cai Zhongdi, Liu Rui
Primary Institution: Institute of Medicinal Biotechnology, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China
Hypothesis
Can miR-25802 be targeted to regulate neuroinflammation in Alzheimer's disease?
Conclusion
The study suggests that miR-25802 plays a significant role in neuroinflammation related to Alzheimer's disease and could be a potential therapeutic target.
Supporting Evidence
- miR-25802 is significantly upregulated in the plasma of Alzheimer's disease patients.
- Inhibiting miR-25802 shifts microglia toward an anti-inflammatory phenotype.
- Overexpression of miR-25802 exacerbates cognitive impairment in Alzheimer's disease mouse models.
- Targeting miR-25802 may offer novel therapeutic approaches for Alzheimer's disease.
Takeaway
Researchers found that a tiny molecule called miR-25802 can help control inflammation in the brain, which is important for treating Alzheimer's disease.
Methodology
The study utilized high-throughput sequencing, bioinformatics, dual-luciferase reporter assays, gain- and loss-of-function experiments, qRT-PCR, and Western blot analyses.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website